West Pharmaceutical Services (NYSE: WST)
West Pharmaceutical Services Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
West Pharmaceutical Services Company Info
West Pharmaceutical Services, Inc. manufactures and markets pharmaceuticals, biologics, vaccines and consumer healthcare products. It operates through the following business segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers proprietary packaging, containment and drug delivery products, along with analytical lab services, to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business, focused on the design, manufacture and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. The company was founded by Herman O. West on July 27, 1923 and is headquartered in Exton, PA.
News & Analysis
Why West Pharmaceutical Services Stock Is Heading South Today
The company reported disappointing Q3 results.
Have $1,000? Here Are 3 Top Healthcare Stocks to Buy in December
There are plenty of healthcare stocks that have seen share growth this year. Here are three lesser-known stocks that have the potential to continue that growth this month and beyond.
These 2 Under-the-Radar Stocks Could Be Key to Coronavirus Vaccine Distribution
While vaccine makers get all the headlines, these equipment providers are critical to the global supply chain.
These 10 Healthcare Stocks Are the Biggest S&P 500 Winners of 2020
Savvy investors should consider adding these stocks to their portfolio to enhance its performance and diversity.
These 5 Healthcare Stocks Are the Biggest S&P 500 Winners of 2020
Some of the names on this list may surprise you.
Forget the Inverted Yield Curve, These 3 Stocks Just Hit All-Time Highs
The charts for these three stocks show the kinds of curves that investors should really like -- trending upward.
Why West Pharmaceutical Services Is Rising Today
Wall Street cheers the company's first-quarter earnings report.
Valuation
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.